AEVEX investors have until Oct. 20 to seek lead plaintiff role

  • Eligible AEVEX investors can seek lead plaintiff status in a proposed securities class action alleging concealed post-IPO lock-up plans.
  • AEVEX announced plans to sell eight million additional Class A shares in a secondary offering, after which the stock fell approximately 16%, according to the complaint.
  • The October 20, 2026, deadline applies to investors who bought shares in or traceable to the April 2026 IPO or during the April 17-June 4 class period.

Investors who purchased or acquired AEVEX Corp. Class A common stock in or traceable to the company's April 2026 initial public offering, or between April 17 and June 4, 2026, have until October 20, 2026, to seek appointment as lead plaintiff in a proposed securities class action. Rosenberg v. AEVEX Corp., No. 26-cv-04779, is pending in the U.S. District Court for the Southern District of California. The complaint alleges that AEVEX, Madison Dearborn Partners, LLC, certain executives and directors, and IPO underwriters misled investors by concealing a plan to waive Madison Dearborn Partners' stated 180-day lock-up and conduct a secondary public offering soon after the IPO. AEVEX's June 1 registration statement announced plans to sell eight million additional Class A shares, after which the stock fell approximately 16%, according to the complaint; shares fell another 7% after the June 5 filing of the final prospectus allegedly disclosed the lock-up arrangement. Eligible investors may participate in any potential recovery without serving as lead plaintiff.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.